Immunitybio Inc (IBRX)

Stock-Based Compensation

$8.52M

Quarterly · Period ending: · USD

IBRX logo

IBRX Stock-Based Compensation

Latest reported$8.52M
IBRX Quarterly Stock-Based Comp ($135.00K → $8.52M)
High-resolution chart · PNG

IBRX stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
8,518,000
8,169,000
8,746,000
8,878,000
9,648,000
9,537,000
9,038,000
7,489,000
9,639,000
8,266,000
12,774,000
14,449,000
11,062,000
10,878,000
9,350,000
10,630,000
10,175,000
10,024,000
10,180,000
13,840,000
17,863,000
15,298,000
671,000
714,000
322,000
480,000
0
277,000
522,000
1,351,000
1,407,000
3,968,000
8,934,000
9,073,000
8,884,000
8,714,000
9,381,000
10,018,000
11,266,000
18,669,000
23,382,000
20,535,000
70,554,000
36,103,000
80,041,000
24,523,000
593,000
29,000
32,000
135,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.